Coupang Cash & Equivalents decreased by 0.3% to $6.39B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 3.1%, from $6.20B to $6.39B. Over 5 years (FY 2020 to FY 2025), Cash & Equivalents shows an upward trend with a 35.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher levels indicate strong liquidity and financial flexibility; lower levels may signal potential cash flow issues.
This represents the most liquid assets held by the company, including cash on hand, demand deposits, and short-term inve...
A universal metric for assessing a company's immediate financial health.
cash_and_equivalents| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.46B | $4.27B | $3.81B | $3.68B | $3.27B | $3.06B | $3.69B | $4.12B | $4.74B | $5.26B | $5.60B | $5.57B | $5.79B | $5.96B | $6.03B | $6.20B | $6.89B | $7.32B | $6.41B | $6.39B |
| QoQ Change | — | -4.3% | -10.8% | -3.5% | -11.0% | -6.5% | +20.5% | +11.9% | +15.0% | +10.9% | +6.4% | -0.4% | +3.9% | +2.9% | +1.2% | +2.8% | +11.1% | +6.3% | -12.5% | -0.3% |
| YoY Change | — | — | — | — | -26.6% | -28.3% | -3.2% | +12.1% | +45.0% | +71.9% | +51.8% | +35.2% | +22.1% | +13.3% | +7.8% | +11.2% | +18.9% | +22.8% | +6.3% | +3.1% |